Direct medical costs associated with exacerbations related to non-cystic fibrosis bronchiectasis

Pulmonary exacerbations in cystic fibrosis and bronchiectasis.

unique characteristics. Taking these characteristics into account should enable a more accurate assessment of disease severity. Numerous examples exist of disease-specific scores that outperform generic scores, 14 including the PSI in the context of patients hospitalised with CAP. The study by Barlow et al extends this view to CURB65 in relation to SEWS and SIRS. However, the patient cohort in ...

Non-cystic fibrosis bronchiectasis.

Bronchiectasis is characterized by irreversible widening of the medium-sized airways, with inflammation, chronic bacterial infection and destruction of the bronchial walls. Exercise or inspiratory muscle training may improve quality of life and exercise endurance in people with non-cystic fibrosis bronchiectasis. Prolonged-use antibiotics improve clinical response rates, but may not reduce exac...

Non-cystic Fibrosis Bronchiectasis

Non-cystic fibrosis bronchiectasis.

Bronchiectasis is a chronic debilitating condition with considerable phenotypic diversity. A vicious cycle of infection and inflammation exists in damaged airways with patients suffering from persistent cough, purulent sputum production, recurrent chest infections and general malaise. The associated burden of disease in terms of increased morbidity, reduced quality of life and the socioeconomic...

Outcome of Cystic Fibrosis in Patients with Bronchiectasis

Introduction: Bronchiectasis is a common problem in children especially under 5 years. Early diagnosis of disease and its causes could be useful in early treatment and preventing probable complications. This study aimed at evaluating the cystic fibrosis (CF) in patients with  bronchiectasis. Methods: In a cross-sectional study, 374 children with bronchiectasis were studied. The diagnosis was ma...